Coverage
-
November 09, 2022
A California federal judge granted final approval to a $13.5 million settlement between chemical products manufacturer Amyris Inc. and investors who claimed the company overstated its royalty revenue, while awarding class counsel $3.3 million in attorney fees.
1 other articles on this case.
View all »